Difference between revisions of "Gastric adenocarcinoma and proximal polyposis of the stomach"

From Libre Pathology
Jump to: navigation, search
(Criteria)
(tweak)
 
Line 4: Line 4:
 
*Very rare.
 
*Very rare.
 
*APC promotor IB mutations.<ref name=pmid30584346/>
 
*APC promotor IB mutations.<ref name=pmid30584346/>
 +
*Autosomal dominant inheritance.<ref name=pmid30584346/>
  
 
==Criteria==
 
==Criteria==
Line 11: Line 12:
 
**Histology predominantly [[fundic gland polyp]]s - some with dysplasia or adenocarcinoma in background.
 
**Histology predominantly [[fundic gland polyp]]s - some with dysplasia or adenocarcinoma in background.
 
*No colorectal or duodenal polyposis.
 
*No colorectal or duodenal polyposis.
*Autosomal dominant inheritance.
+
*Exclusion of other heritable polyposis syndrome involving the stomach, proton pump inhibitor (PPI) use.
*Exclusion of other heritable polyposis syndrome involving the stomach, PPI use.
 
  
 
==See also==
 
==See also==
Line 22: Line 22:
 
[[Category:Diagnosis]]
 
[[Category:Diagnosis]]
 
[[Category:Syndromes]]
 
[[Category:Syndromes]]
 +
[[Category:Stomach]]

Latest revision as of 11:49, 16 September 2019

Gastric adenocarcinoma and proximal polyposis of the stomach, abbreviated GAPPS, is a rare syndrome characterized by fundic gland polyps and gastric adenocarcinoma.[1][2]

General

  • Very rare.
  • APC promotor IB mutations.[1]
  • Autosomal dominant inheritance.[1]

Criteria

Features - all required:[1]

  • Polyps of stomach - body and fundus only.
    • >100 polyps in index case or >30 polyps in first degree relative.
    • Histology predominantly fundic gland polyps - some with dysplasia or adenocarcinoma in background.
  • No colorectal or duodenal polyposis.
  • Exclusion of other heritable polyposis syndrome involving the stomach, proton pump inhibitor (PPI) use.

See also

References

  1. 1.0 1.1 1.2 1.3 Rudloff, U. (2018). "Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives.". Clin Exp Gastroenterol 11: 447-459. doi:10.2147/CEG.S163227. PMID 30584346.
  2. Worthley, DL.; Phillips, KD.; Wayte, N.; Schrader, KA.; Healey, S.; Kaurah, P.; Shulkes, A.; Grimpen, F. et al. (May 2012). "Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.". Gut 61 (5): 774-9. doi:10.1136/gutjnl-2011-300348. PMID 21813476.